Gadoxetate
- TRADE NAMES: Eovist (Bayer); Primovist (Bayer)
- INDICATIONS: Magnetic resonance imaging (MRI) of the liver
- CLASS: Gadolinium-based contrast agent (GBCA)
- HALF-LIFE: ~1.0 hour
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Anionic drugs, Rifampin
PREGNANCY CATEGORY: C
NEPHROGENIC SYSTEMIC FIBROSIS
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric